Page 367 - கடுமையானது எடுப்போசை சுவாச நோய்க்குறி News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Com 3 774 mortes por Covid-19 em 24 horas, média móvel ainda se mantém próxima de 3 mil
globo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globo.com Daily Mail and Mail on Sunday newspapers.
Covid-19: Média de mortes maternas dispara 113% em 2021 em relação a 2020
ig.com.br - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ig.com.br Daily Mail and Mail on Sunday newspapers.
Mortes por coronavírus nas regiões de Rio Preto e Araçatuba em 15 de abril
globo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globo.com Daily Mail and Mail on Sunday newspapers.
Faculty voice: Asian America’s invisibility has roots in history
Sometime in the early 1950s, a revelation struck Tadachi Kohara, a Japanese American survivor of the Hiroshima atomic bombing in 1945: “White people believed that we survivors had a bad disease.” Worse yet, the disease was deemed contagious, something that Kohara believed was evidenced by a peculiar way in which white people acted: “On a bus, they escaped from a seat next to a Japanese.” Born in San Fernando, California, in 1929, and returning to America from Japan (where he spent the war years) in 1950 as a young man, Kohara is one of many U.S. survivors of the Hiroshima and Nagasaki atomic bombings, a subject I explore in my book “American Survivors: Trans-Pacific Memories of Hiroshima and Nagasaki”
Press release content from Business Wire. The AP news staff was not involved in its creation.
GenScript Biotech BV and IES Diagnostics Forge Distribution Agreement for SARS-CoV-2 Neutralizing Antibody Kit
April 14, 2021 GMT
LEIDEN, Netherlands & BILBAO, Spain (BUSINESS WIRE) Apr 14, 2021
ADVERTISEMENT
The test measures the presence of neutralizing antibodies (NAbs) in patients recovering from COVID-19 or receiving a vaccine. It is the only U.S. FDA Emergency Use Authorized (EUA) serology test for neutralizing antibodies from recent and prior SARS-CoV-2 infections. The kit is also CE marked (Europe) and has received HSA provisional approval (Singapore), ANVISA in Brazil, ANMAT in Argentina and has recently received clearance from the Ministry of Health and Prevention (MOHAP) in the United Arab Emirates as a medical device.